ArticleEuropean journal of medical research2025
Global, regional, and national epidemiology of neurological disorders and subcategories: incidence and disability-adjusted life years, 1990-2021.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Discovery of tricyclic benzo[4,5]imidazo[2,1-RSC advances · 2026Article
- Patient and therapist experiences of a self-management group programme for fatigue in primary care: a qualitative study.BMC primary care · 2026Article
- Physical frailty, depressive symptoms, and cognitive decline before and after Parkinson's disease diagnosis: a population-based prospective study of the SHARE and ELSA cohorts.NPJ Parkinson's disease · 2026Article
- A narrative review of clinical and non-clinical determinants of health-related quality of life in advanced Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- National and subnational burden of neurological disorders in Iran, 1990 to 2021: results from the global burden of disease study 2021.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
- Trends in the Burden of Headache Disorders in Europe, 1990-2021: A Systematic Analysis from the Global Burden of Disease Study 2021.Journal of clinical medicine · 2025Article
- Article
- Exploring the gut microbiota-Parkinson's disease link: preliminary insights from metagenomics and Mendelian randomization.Frontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesTo multi-dimensional analyze global trends and inequalities in the burden of neurological disorders (NDs) and subcategories from 1990 to 2021, and provide clues for policymakers to formulate relevant prevention and control strategies.
methodsUsing data from the Global Burden of Disease Study 2021, we assessed trends in incidence and disability-adjusted life years (DALYs) and estimated the annual percentage change (EAPC) for NDs and their eight subcategories. Cross-country inequalities and decomposition were quantified for DALYs. Analyses were stratified by Socio-Demographic Index (SDI), age, sex, and region.
resultsGlobally, age-standardized incidence (ASIR) and DALY rates (ASDR) remained stable, but marked heterogeneity existed across subcategories. Tension-type headache (ASIR: 87%) and migraine (ASDR: 40%) dominated burdens in 2021. Parkinson's disease and migraine exhibited rising trends (ASIR-EAPC: 1.09% and 0.07%; ASDR-EAPC: 0.32% and 0.05%, respectively). Females bore higher burdens for migraine, multiple sclerosis, and Alzheimer's disease and other dementias, with disparities widening in older age groups. Middle SDI regions, particularly East Asia (EAPC: 0.22%) and China (0.23%), saw accelerating ASIR. ASDR grew fastest in Western Sub-Saharan Africa (0.22%) and Zambia (0.62%). Cross-country inequality indices revealed worsening disparities, concentrating burden in high SDI countries, while idiopathic epilepsy persistently clustered in low SDI populations. Population growth (64.21%) and aging (35.33%) drove DALYs increase, with aging disproportionately impacting high- and high-middle SDI regions.
conclusionsThe burden of NDs demonstrates significant age, sex, and socioeconomic heterogeneity. Prioritizing resource equity and tailored policies is critical to achieving targets. High SDI regions require aging-focused interventions, while low/middle SDI regions need population-level strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.